🧾 What This Document Is

This is an 8-K filing, which companies use to announce major news to investors. Specifically, this contains Exhibit 99.1, which is NextPlat's press release announcing its financial results for the full year 2025. It's a "turnaround" report, detailing how the company is cutting costs and changing its business to become profitable.

🏢 What The Company Does

👉 In simple terms, NextPlat is a two-business company. One side provides healthcare services, mainly through a pharmacy subsidiary called Progressive Care, where they fill prescriptions and offer data management. The other side is an e-commerce division that sells satellite communication and IoT (Internet of Things) products globally. They're trying to shift their healthcare business to more profitable services and grow their tech sales.

💰 Financial Highlights: The 2025 Scorecard

Revenue fell, but the story is about cost control and a changing business mix.

• Revenue: $54.3 million for 2025, down 18% from $66.1 million in 2024.
  • 👉 Why it matters: The drop is mainly because they filled fewer prescriptions (374k vs. 473k), but they're intentionally moving away from lower-margin retail pharmacy work.
• Profitability (Gross Margin): Dropped to 20% from 26% the year before.
  • 👉 Why it matters: The lower margin reflects the temporary loss of some high-margin healthcare contract revenue. The company says this is reversing as they sign new contracts in late 2025.
• The Losses Continue (But Shrink): Net loss was $11.7 million ($0.44 per share), better than the $13.4 million loss ($0.65 per share) in 2024.

🚀 Key Moves: The Turnaround in Action

Management made sweeping changes to stop the bleeding and refocus.

• Massive Cost Cutting: Operating expenses were slashed by 50% to $19.9 million from $40.0 million. This included a 20% cut to salaries/wages and a 49% cut to professional fees.
  • 👉 Why it matters: This is the core of the turnaround—drastically reducing the "burn rate" to get closer to profitability.
• New Leadership Team: Appointed a new Chairman (Rodney Barreto), CEO (David Phipps), CFO (Amanda Ferrio), and VP of Healthcare (Birute Norkute).
• Strategic Pivot in Healthcare: They stopped chasing low-margin prescription volume and started a dedicated sales team to target the 340B drug pricing program and long-term care facilities. They now serve over 6,000 prescriptions per month via these new, higher-margin services.

📦 Financial Position: What's in the Bank?

The company's liquidity is stable, which gives it runway for its plans.

• Cash: Ended 2025 with $13.7 million in cash.
• Debt: Has "no meaningful unsecured debt."
• Working Capital: A healthy $15.0 million (current assets minus current liabilities).

💸 Cash Flow Story

While the detailed cash flow statement isn't here, the key takeaway is the result of their actions. The aggressive cost cuts ($2+ million in annualized savings) and reduced losses are designed to conserve cash and move the company toward positive operational cash flow in 2026.

🔮 What's Next: Guidance for 2026

The company is publicly forecasting a better future.

• They believe they are now on a "profitability pathway" for 2026.
• They plan to expand nationwide in medication fulfillment, potentially through a partnership with Healthwarehouse.com and new direct-to-consumer websites.
• They are evaluating growth opportunities like acquisitions and joint ventures.
• They will host a conference call on March 31, 2026, at 8:30 a.m. ET to discuss the results. (See dial-in details in the Key Contacts section below).

⚖️ Big Picture: Strengths & Risks

👍 Strengths / What's Working:

• Cost Discipline: The 50% reduction in operating expenses is dramatic and creates a leaner company.
• Strategic Pivot: Moving toward higher-margin 340B and fulfillment services makes economic sense.
• E-Commerce Momentum: Set annual sales records for satellite devices (5,000+) and trackers/messengers (12,000+).
• Strong Cash Position: $13.7 million in cash provides a cushion.

⚠️ Risks / What to Watch:

• Execution Risk: Can the new leadership successfully execute the nationwide expansion and hit profitability targets?
• Revenue Decline: Revenue is still falling as they exit the old business model. The new model must grow fast enough to offset this.
• Margin Recovery: Gross margins need to recover to previous levels for the profit formula to work.
• Market Competition: Both the healthcare and satellite communications industries are competitive.

🧠 The Analogy

Think of NextPlat as a renovating restaurant. It was losing money serving cheap, popular burgers (low-margin prescriptions). The new chef (management) has fired staff, closed unused dining areas (cost cuts), and is now focused on selling premium, high-margin tasting menus and catering contracts (340B and fulfillment services) while also launching a popular line of gourmet sauces for home chefs (satellite e-commerce). The 2025 report shows the renovation is messy and revenue is down, but the owner believes the new menu will pack the house in 2026.

📇 Key Contacts & People

Company: NextPlat Corp, 1200 East Hallandale Beach Blvd, Suite 505, Hallandale Beach, FL 33009

• David Phipps, Chief Executive Officer and President
• Amanda Ferrio, Chief Financial Officer
• Birute Norkute, Vice President of Healthcare Operations
• Rodney Barreto, Chairman of the Board

Conference Call Info (March 31, 2026):

• Time: 8:30 a.m. Eastern time
• Toll-Free Dial-In: 1-800-836-8184
• International Dial-In: 1-646-357-8785
• Webcast Link: https://app.webinar.net/wbRv9ab8NLa
• Replay (available after 12:00 p.m. ET through April 7):
  • Toll-Free: 1-888-660-6345
  • International: 1-646-517-4150
  • Replay Entry Code: 97518#
• Investor Relations Website: https://ir.nextplat.com

🧩 Final Takeaway

NextPlat is a company in the middle of a painful but aggressive transformation. In 2025, it successfully cut its cash burn in half and re-focused its healthcare business on more profitable services. While revenue and margins fell during the transition, the leadership is promising a return to growth and profitability in 2026, backed by a solid cash balance. The bet is that a leaner, strategically-focused company can now deliver on its promises.